Metiamide caused a further reduction in both sets of dilatation.
Neither single nor combined antihistamines reduced dilatation due to exercise or after temporary occlusion of the circulation in the hindlimb. Poststimulation dilatation in the gracilis muscle was partially attenuated by metiamide or mepyramine.
Neither dilatation caused by sympathetic nerve stimulation in the hindpaw nor dilatation in the gracilis muscle caused by compound 48/8O was reduced by mepyramine. Following combined H,-and HZ-receptor blockade, portions of both types of dilatation were reduced. These data provide evidence for the participation of both types of histamine receptor in active reflex dilatation, low-frequency neurogenic dilatation, dilatation caused by compound 48/80, and poststimulation dilatation.
Neither type of histamine receptor appears to be involved in reactive hyperemia or dilatation caused by exercise. anesthetized dog; mepyramine; metiamide; neurogenic vasodilatation; compound 48/80; exercise; reactive hyperemia THE PRESENCE OF LARGE AMOUNTS ofhistaminein and near blood vessels and the profound vascular actions of this substance have caused many investigators to propose that histamine is the mediator of several forms of vasodilatation. Lewis (ZO), in a classic description of the cutaneous circulation, proposed histamine (H-substance) as the mediator of postocclusion-reactive hyperemia. Anrep et al. (2) reported the release of histamine from exercising human forearm muscles and suggested that histamine mediates exercise hyperemia. Histamine has been postulated to mediate the active component of baroreceptor-mediated reflex vasodilatation (4-7, 9-11, 16, 19, 25) .
Recently, two distinct types of histamine receptor have been described (8) . The first type is blocked by classical antihistamines such as mepyramine and is designated as type H,. The second is designated as type H, and is blocked by metiamide or burimamide. H, and H, receptors have been shown to mediate the cardiovascular actions of histamine in the dog (18, 23, 24) . In the dog, mepyramine, a type H1 blocker, can only partially attenuate vasodilatation caused by histamine. When an H, blocker such as metiamide is given alone, it has no effect on vasodilatation caused by histamine. However, when metiamide is given subsequent to mepyramine, a large attenuation of the vasodilatation due to histamine is obtained. The use of the specific HZ-receptor agonist, 4-methylhistamine, has allowed for the demonstration that H, receptors are activated in the absence of previous HI-receptor blockade (24) .
The purpose of this investigation was to examine the effects of H, and H, antihistamines on several forms of vasodilatation which have been proposed to involve the release of endogenous histamine. It is proposed that, by use of the new H, antihistamines, several forms of physiological vasodilatation might be shown to involve histamine through activation of H, receptors.
METHODS
All experiments were conducted in mongrel dogs of either sex (body wt 18.5 t 0.4 kg, mean t SE) anesthetized with sodium pentobarbital (30 mg/kg iv). The trachea was cannulated and the animals were allowed to breathe room air spontaneously. The brachial artery was cannulated for blood pressure measurement and the brachial vein cannulated for the systemic administration of drugs.
Baroreceptor-mediated active reflex vasodilatation. The right common iliac artery was isolated through a short midline abdominal incision. After heparin administration (1,000 U/kg iv), the vessel was cannulated and perfused with a Sigmamotor pump at constant flow using blood obtained from the left femoral artery. The femoral arterial cannula was advanced into the abdominal aorta, and the aorta was ligated proximal to the iliac bifurcation to improve the vascular isolation of the perfused limb. Perfusion pressure was measured between the pump and hindlimb. A flow rate generating a perfusion pressure that approximated arterial pressure was chosen and held constant so that changes in vascular resistance were reflected directly by changes in perfusion pressure. In nine experiments flow averaged 81 t 10 nl/min. All animals were vagotomized and artificially ventilated with ro.om air.
Reflex vasodilatation in the hindlimb was elicited by the intravenous administration of norepinephrine. The perfusion system provided a sufficient delay (62 t 9 s) so that intravenously administered norepinephrine did not cause vasoconstriction in the perfused hindlimb until well after the reflex vasodilatation had reached its nadir. Histamine, norepinephrine, and glyceryl trinitrate were injected into the limb through the perfusion tubing near the site of cannulation.
Then In this series of experiments, the gracilis muscle was perfused as described by Dorr and Brody (13) . Flow to the gracilis muscle was 12 t 2 ml/min. The lumbar sympathetic chain was isolated and sectioned at a level of L4 or L5. The peripheral end was stimulated with square-wave electrical impulses at supramaximal voltage and with frequencies from 0.25 to 3.0 Hz. The duration of each impulse was 2 ms, and the total duration of stimulation was 5 min. Poststimulation dilatation and responses to histamine and glyceryl trinitrate were obtained before and after metiamide (30 mg) and after the subsequent administration of mepyramine (30 mg), or before and after metiamide or mepyramine alone.
Reactive hyperemia. Postocclusion reactive hyperemia was studied in the common iliac artery of the dog. The artery was exposed and an electromagnetic flow probe was placed on it near the aorta. Approximately 2 cm distal from the probe, the artery was fitted with a snare for occlusion. The saphenous artery was cannulated and a small-diameter polyethylene tube (PE-50) was passed retrogradely until its tip was just proximal to the flow probe. This cannula was used for local drug injections.
By use of the snare, the vessel was totally occluded for 5, 10, 15, and 30 s. Responses in the hindpaw to nerve stimulation, histamine, and glyceryl trinitrate were obtained before and after the infusion of 15 mg of mepyramine and subsequent to the local infusion of 30 mg of metiamide.
Histamine release by compound 48180. This series of experiments was conducted in the perfused gracilis muscle using methods outlined by Dorr and Brody (13) . In these experiments, flow was 14 t 2 ml/min. Vasodilator responses were obtained to the local injections of histamine, compound 48/80, and gl .yceryl trinitrate. Then, 15-30 mg of mepyramine were infused over a lomin period and responses were again obtained. Following mepyramine, 30 mg of metiamide were infused and responses were again obtained.
StatisticaL analysis. All drugs except the antihistamines were administered in a random fashion, and data were analyzed by means of paired-t tests as outlined by Steele and Torrie (27). Figure 1 illustrates the blood pressure and perfusion pressure responses in the dog hindlimb produced by the intravenous administration of norepinephrine. The responses in the hindlimb are expressed as a "dilator ratio ," obtained by dividing the change in perfusion pressure by the perfusion pressure immediately preceding the response. Both doses of norepinephrine caused an increase in arterial pressure and a reflex decrease in perfusion pressure.
RESULTS
Because flow was maintained constant to the hindlimb, this fall in perfusion pressure represents vasodilatation. Vasodilator responses in the hindlimb to the local intra-arterial injection of histamine are also shown. The local intra-arterial administration of mepyramine (middZe panel) caused a reduction in the magnitude of the reflex dilatation produced in response to norepinephrine. The responses to histamine obtained after mepyramine were also significantly reduced. The right-hand panel shows that the vasodilator responses following systemic norepinephrine were further reduced following metiamide treatment for the low dose of norepinephrine. Responses to histamine following metiamide were nearly abolished. The arterial nressure increases following intravenous norepineph- (Table 1) . Mepyramine caused a small reduction in vasoconstriction caused by intra-arterial norepinephrine which was significant for the 3-pg dose only. No further attenuation of vasoconstriction was seen with metiamide. Neither antihistamine attenuated vasodilatation due to intra-arterial glyceryl trinitrate (GTN).
The nature of poststimulation dilatation is illustrated in Fig. 2 . Stimulation of the lumbar sympathetic chain caused vasoconstriction which persisted for the duration of stimulation. At termination of the stimulation, there was a fall in perfusion pressure which exceeded the prestimulation level. This poststimulation dilatation was reduced by metiamide and abolished by mepyramine. Vasodilator responses after histamine were not altered by metiamide but were attenuated after the administration of mepyramine. Results from several similar experiments are shown in Fig. 3 . Metiamide caused a small but significant attenuation of poststimulation dilatation. Metiamide did not attenuate vasodilatation after histamine. The further addition of mepyramine caused an additional attenuation of poststimulation dilatation and nearly abolished vasodilatation due to histamine. In two additional experiments, the administration of mepyramine alone partially attenuated vasodilatation after histamine and abolished poststimulation vasodilatation. Neither antihistamine reduced significantly the magnitude of vasoconstriction caused by electrical stimulation of the lumbar sympathetic nerves or vasodilatation caused by glyceryl trinitrate. Reactive hyperemia in the dog hindlimb is shown in Fig. 4 . Occlusion of the iliac artery caused cessation of flow for the duration of the occlusion. Following release of the occlusion, there was a transient hyperemia as indicated by the increases in flow over preocclusion values. As shown on the right, the intra-arterial injection of histamine also caused vasodilatation. Several similar experiments are summarized in Fig. 5 . Following intra-arterial mepyramine, there was little change in the hyperemic responses and a reduction in responses to histamine. Further treatment with metiamide caused an additional attenuation of histamine-induced vasodilatation, but had no effect on reactive hyperemia or dilator responses to GTN.
Stimulation of the peripheral end of the decentralized sciatic nerve caused intermittent flexion of the limb and a coincident reduction in vascular resistance. The nature of this response is shown in Fig. 6 . The dilatation during exercise of the limb is shown by the reductions in perfusion pressure. This dilatation was rapid in onset and persisted for several minutes when the stimulation of the sciatic nerve was terminated. Vasodilatation was also caused by the local intra-arterial injection of histamine. Following mepyramine, the responses to histamine were attenuated and a further attenuation was caused by metiamide. Neither antihistamine attenuated the vasodilatation associated with exercise. A statistical summary of these responses is shown in Fig.   7 . Stimulation of the sciatic nerve caused a large vasodilatation which was dependent on the frequency of the stimulus. Neither antihistamine caused an attenuation of the vasodilator responses during exercise of the limb; in fact, the average responses tended to be greater than control after each antihistamine.
A neurogenic vasodilator system is unmasked in the dog hindpaw after treatment with atropine and bretylium tosylate (3, 6, 12, 31) . After drug treatment, electrical stimulation of the decentralized lumbar sympathetic chain causes a profound long-lasting vasodilatation. The effect of H, and H, antihistamines on sustained neurogenic vasodilatation is shown in Fig. 8 . Electrical stimulation of the lumbar chain at 3 and 10 Hz, histamine, and glyceryl trinitrate-all caused dilatation in the perfused hindpaw. After mepyramine, only the vasodilator responses to histamine were attenuated. After subsequent treatment with metiamide, there was a further attenuation of responses to histamine and an attenuation of the neurogenic dilator responses obtained at low frequency. Although not shown in the figure, vasodilator responses produced by stimulation at 30 Hz were unaffected.
The effects of the histamine releasing agent, compound 48/80, on vascular resistance were examined in the isolated blood-perfused gracilis muscle of the dog. As shown in Fig. 9 , compound 48/80 caused a dosedependent decrease in perfusion pressure. Mepyramine treatment did not alter the vasodilatation caused by compound 48/80 but did attenuate vasodilatation produced by histamine. The subsequent administration of metiamide caused a further reduction in vasodilatation due to histamine and reduced dilatation caused by compound 48/80. Although not shown in this figure, neither antihistamine caused a reduction in the vasodilatation caused by glyceryl trinitrate.
DISCUSSION
The presence of large amounts of histamine in tissues and the profound vascular actions of this substance have long suggested a possible role for histamine in the regulation of the peripheral circulation. Heitz and Brody (16) described a dilator system in the dog gracilis muscle which is under reci.procal control of the sympathetic nervous system. These authors showed that when neurogenic vasoconstrictor tone to the decentralized muscle was restored by electrical stimulation of the sympathetic nerves that, at termination of stimulation, an antihistamine--sensitive dilatation ensued. Sympathetic vasoconstriction was not required for the poststimulation dilatation since p-xylocholine ether (P-TMlO), a noradrenergic antirelease agent, prevented vasoconstriction during nerve stimulation but did not prevent the poststimulation dilatation. This system appeared to be under adrenergic control because treatment with the a-adrenergic blocker, phentolamine, prevented the poststimulation dilatation.
This concept of reciprocal control of a histaminergic system is consistent with the concept of histamine mediation of reflex dilatation outlined by Beck (5 Fig. 7 . After mepyramine, mean differences from control responses to histamine were 20 rf: 5,17 + 5, and 14 ~fr 6 mmHg for l-, 3-, and lo-pg doses of histamine, respectively.
Mean differences in responses after metiamide from those after mepyramine were 11 + 4,20 + 5, and 24 + 6 mmHg for l-, 3-, and lo-pg doses of histamine.
Mean differences + SE in responses to 30 and 100 pg of compound 48/80 after metiamide as compared to those after mepyramine were 11 + 4 and 13 + 2 mmHg, respectively.
component involves the release of histamine. This has been demonstrated experimentally by Beck et al. (7) and Brody (11). Release of histamine during nerve stimulation in the dog that is associated with dilatation has also been described by Lioy and White (21) and in the cat by Tuttle (28, 29) . Weaver and Gebber (SO), in an electrophysiological analysis of nerve activity in the lumbar sympathetic chain, found no evidence of nerve fibers whose activity increased during baroreceptor-mediated dilatation, thus confirming the fact that reflex vasodilatation involves only sympathoinhibition. Ryan and Brody (25) measured histamine in dog skeletal muscle, the major site of baroreceptor-mediated active reflex vasodilatation, and found high levels of histamine which did not decrease after denervation.
These authors proposed that the storage site of vascular histamine may be non-neuronal and under reciprocal control of the adrenergic nerves, i.e., when adrenergic discharge 1s inhibited the stabilizing effect of norepinephrine on the histamine pool is lost and histamine is liberated. The pharmacologic evidence for histamine mediation of active reflex dilatation was obtained originally with the use of classical antihistamines of the HI-receptor type. There are numerous reports of partial attenuation of the active component of reflex vasodilatation by H, antihistamines in the dog (4-7, g-11), cat (28), and monkey (19). In the dog, H, and H, antihistamines block histamine responses in .a specific manner (23, 24). H, antihistamines given alone have little or no effect on histamine-induced dilatation.
H, antihistamines such as mepyramine cause a partial attenuation of responses to histamine.
However, when H, antihistamines are added, there is specific additional inhibition of responses to histamine.
In another study (24), it was determi ned that histamine was the only one of several vasodilators to be affected in this specific manner. The parallel reduction of responses to histamine and the reflex vasodilatation caused by increasing arterial pressure by the sequential administration of H, and H, antihistamines provides additional pharmacological evidence for histamine mediation of the active component of reflex vasodilatation and provides new evidence for the participation of H, receptors. Examination of Fig. 1 reveals that the magnitude of the reduction in dilatation was greater for the exogenous administration of histamine than for the reflex vasodilatation.
In light of the two components that constitute reflex vasodilatation, namely the active and passive components, this is to be expected. A large portion of the reflex dilatation is due to the passive withdrawal of adrenergic vasoconstrictor tone from the hindlimb (4, 5). This portion would not be expected to be altered by the antihistamines.
The findings that neither vascular tone, as reflected by perfusion pressure, nor reflex vasoconstrictor responses were reduced by either or both antihistamines further indicate that the attenuation of reflex vasodilatation did not involve the passive component, i.e., that portion of the response produced by withdrawal of adrenergic vasoconstrictor tone. Vascular responsiveness did not appear to be altered because there were no significant modifications of responses of glyceryl trinitrate or intra-arterial norepinephrine. It follows, therefore, that the portion of the dilatation that was reduced with combined antihistamines represents the contribution of histamine to the dilatation because responses to exogenous histamine were nearly abolished.
Heitz and Brody (16) reported that poststimulation vasodilatation in the dog gracilis muscle was nearly abolished by tripelennamine as were responses to small doses of histamine. This would suggest that only H, receptors participate in this response. In this current study, H, blockade by metiamide had little effect on responses to histamine but did cause a significant attenuation of the poststimulation dilatation. This could suggest that 1) metiamide has a weak H, receptor-blocking effect; 2) metiamide has a nonantihistamine effect on a nonhistamine mechanism; or 3) during poststimulation dilatation, a portion of the response involves H,-receptor activation.
The first proposal seems unlikely because metiamide in the doses used has no effect on responses to a specific HI-receptor agonist 2-(2-pyridyl)-ethylamine (24). The second proposal also seems unlikely because metiamide has been shown to have no effects on vascular responses to nitroglycerin, acetylcholine, isoproterenol (24)) bradykinin (18)) or norepinephrine (Table 1) . It would appear therefore that a portion of the response involves HZ-receptor activation.
As in most vasodilator responses in the dog involving histamine, the majority of this response appears to involve H, receptors. This is evidenced by the complete, or nearly complete, abolition of poststimulation dilatation by mepyramine alone or by mepyramine following metiamide. The involvement of H, receptors is shown by the partial attenuation of the dilatation by metiamide given alone. The H, receptors activated during poststimulation dilatation appear to be different from those activated by the exogenous administration of histamine. This is suggested by the findings that metiamide alone attenuated poststimulation dilatation but not dil-Atten .uation of thi .s dilatation by H, antihistami nes was atation due to exogenous histamine. It would appear found neither by Ballard et al. (3) nor in the present that the H, receptors activated during poststimulation dilatation do not play a major physiological role because the response could be abolished by mepyramine. Lewis (20) proposed that the hyperemia accompanying the removal of an occlusion to the forearm was caused by the liberation of histamine. Indeed, Anrep et al. (2) reported an increased amount of histamine in venous blood from muscle during reactive hyperemia. Duff et al. (14) examined the effects of the antihistamines tripelennamine, antazoline, and mepyramine on postocclusion hyperemia in the human forearm. After 3 min of occlusion, none of the antihistamines had an effect on the magnitude of the hyperemia. However, when the period of occlusion was extended to lo-25 min, there was a partial attenuation of the hyperemia. The data of the present study are in agreement with those of Duff et al. (14) in that the hyperemia after short periods of occlusion is not attenuated by H, antihistamines. However, as described previously, histamine interacts with H, as well as H, vascular receptors in the dog (18, 23, 24) . It was therefore possible that reactive hyperemia could involve histamine as the mediator through activation of H, receptors. The present study provides evidence that the additional blockade of H, receptors by metiamide does not alter the magnitude of the reactive hyperemia. The combined blockade of H, and H, receptors causes a large reduction in histamine-induced vasodilatation without causing a coincident reduction in the hyperemia. These data do not support the postulate of Schayer (26) that histamine is the vasodilator mediator of reactive hyperemia produced by short periods of occlusion, at least not through direct interaction with vascular receptors.
Muscu lar exercise is known to be accompanied by vasodilatation. In the present study, exercise was produced in the dog hindlimb by stimulation of the sciatic nerve. Anrep et al. (2) demonstrated the release of histamine from exercising muscle and suggested that histamine was responsible for the dilatation seen with exercise. It follows that, if histamine mediates exercise hyperemia, then responses to histamine and the hyperemit responses should be reduced in parallel bY H, and H, antihistamines. Such was not the case, however. Histamine-induced responses were attenuated by mepyramine and further attenuated by the subsequent administration of metiamide. Attenuation of the responses to histamine was obtained without a similar attenuation of the dilatation occurring with exercise. This dilatation seen with sciatic nerve stimulation was not neurogenic in origin because no changes in perfusion pressure occurred after neuromuscular blockade with decamethonium. Thus, these data do not support a role for histamine in the mediation of the hyperemia associated with exercise in this study.
Sympathetic vasodilatation in the dog's paw or limb after adrenergic and cholinergic blockade has been described by Zimmerman (31)) Brody and Shaffer (12), and Beck et al. (6) . Zimmerman found that the combination of atropine and the H, blocker, tripelennamine, reduced the magnitude of the sympathetic dilatation in the paw. study. Mepyramine significantly reduced responses to histamine but did not alter neurogenic dilatation or dilatation due to glyceryl trinitrate.
After the further administration of metiamide, there was an additional attenuation of responses to histamine and a reduction in the dilatation obtained by 3 Hz'stimulation. These data provide evidence that histamine may mediate a portion of the low-frequency neurogenic dilatation in the paw. In these studies the dilatation in the hindpaw appears to involve a histaminergic component acting through H, receptors and a component obtained by higher frequencies bf nerve stimulation with a yet unidentified mediator (3, 12, 31) .
In a recent study, Kraft and Zimmerman (18) reported a reduction in the sustained dilator response to nerve sti mulation in the dog hindpaw and a reduction in responses to histamine by H,-and Hz-receptor blockade. However, these authors concluded that this reduction was not due to a specific antihistamine action and instead suggested th at the reduction in sustained dilatation was due to a poten .tiation of residual adrenergic function. Such would not appear to be the case in these studies, however. Enhanced vasoconstrictor effects due to the antihistamines should cause 1) enhanced vasoconstriction due to norepinephrine, 2) enhanced reflex vasoconstriction, or 3) increased vascular tone (measured as perfusion pressure). Because none of these possibilities was observed, it seems unlikely that mepyramine or metiamide causes a potentiation of adrenergic vasoconstrictor effects. As described by Isaac and Goth (17) , some H, antihistamines display a cocainelike effect, i.e., the potentiation of responses to norepinephrine. In that study, mepyramine, unlike some other H, antihistamines, failed to display a cocainelike potentiation of responses to norepinephrine.
Compound 48/80 has been reported by Paton (22) to cause the release of histamine in the dog. After the systemic administration of compound 48/80, there was a fall in blood pressure and an increase in plasma histamine which presumably caused vasodilatation. The effects of H, and H, antihistamines on dilatation associated with the chemically induced release of endogenous histamine were studied in the perfused gracilis muscle. Both histamine and compound 48/80 caused dilatation in the muscle. Mepyramine attenuated the histamineinduced dilatation but not the dilatation associated with compound 48/80. The subsequent administration of metiamide reduced further the responses to histamine and caused a reduction in the dilatation associated with compound 48/80. These results were somewhat unsuspected in light of the pharmacology of compound 48/80, i.e., histamine release, and the effects of H, and H, blockade on histamine-induced responses. However, compound 48/80 not only causes the liberation of histamine, but also releases slow reacting substances (SRS-A), serotonin, and unsaturated fatty acids (1, 22) . It is possible to conclude then that the failure of mepyramine to reduce dilatation after compound 48/80 could be due to the release of nonhistamine vasodilator materials in addition to histamine. Only after the combined blockade of both H, and H, receptors was it possible to reduce the histamine component of the dilatation due to compound 48/80. An alternative hypothesis is that compound 48/80 releases histamine that reacts only with H, receptors. However, in one additional experiment, metiamide given alone failed to attenuate vasodilatation caused by compound 48/80. It is not likely that the reduction in responses to compound 48/80 was due to tachyphylaxis becau se responses produced by repetitive injection of 30 Pg of compound 48/80 were unaltered.
A fourth possibility is that there is different distribution of H, and H, histamine receptors across the vessel wall. It is conceivable that there exists a high concentration of H, receptors on the inner portions of blood vessels. This would allow intra-arterially admi .nistered histamine to act primarily on H, receptors. As described by El-Ackad and Brody (15), there are apparently no histamine-containing mast cells in dog blood vessels. Mast cells are found outside blood vessels, however. Histamine released by compound 48/80 from tissue stores might preferentially interact with the outer portions of vessels. If there is a high concentration of H,
